SUBSCRIBE
SUBSCRIBE
News   Business

Hi-Tech Pharmacal Reports Sales of $57.5 Million and EPS of $0.66 for the Second Quarter Ended October 31, 2012

December 6, 2012 | 
1 min read

AMITYVILLE, N.Y.--(BUSINESS WIRE)--Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today reported results for the Company’s fiscal second quarter ended October 31, 2012.

Earnings
MORE ON THIS TOPIC
Cigna Healthcare office in Delaware
Pharmacy benefit managers
Cigna Continues Biosimilar Push, Targets J&J’s Stelara With No Out-of-Pocket Cost
September 6, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: Novartis' logo outside its building in S
Manufacturing
Novartis Starts Construction on Two US Sites to Bolster Radioligand Therapy Manufacturing
September 5, 2024
 · 
2 min read
 · 
Tristan Manalac
Business growth concept. Vector of a business man hand with pot watering profitable money tree
Business
ArsenalBio Snags Mega $325M Series C Round With Backing from Nvidia, Regeneron
September 4, 2024
 · 
1 min read
 · 
Annalee Armstrong
Pictured: Nasdaq headquarters in New York/iStock,
IPO
Lilly Partner BioAge Files for IPO to Advance Obesity Candidate
September 4, 2024
 · 
2 min read
 · 
Tristan Manalac